Cargando…
Minimal cross-recombination between wild-type and loxP511 sites in vivo facilitates truncating both ends of large DNA inserts in pBACe3.6 and related vectors
Contrary to several earlier reports, we find that cross-recombination between wild-type and the mutant loxP511 sites is <0.5% of that between two wild-type sites if Cre protein is expressed by phage P1 during an infection. The finding enabled us to develop a procedure to truncate DNA progressivel...
Autores principales: | Shakes, Leighcraft A., Garland, Douglas M., Srivastava, Deepak K., Harewood, Ken R., Chatterjee, Pradeep K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1182172/ https://www.ncbi.nlm.nih.gov/pubmed/16061933 http://dx.doi.org/10.1093/nar/gni119 |
Ejemplares similares
-
Generating libraries of iTol2-end insertions at BAC ends using loxP and lox511 Tn10 transposons
por: Shakes, Leighcraft A, et al.
Publicado: (2011) -
Replacing the wild type loxP site in BACs from the public domain with lox66 using a lox66 transposon
por: Chatterjee, Pradeep K, et al.
Publicado: (2010) -
Utilizing the LoxP-Stop-LoxP System to Control Transgenic ABC-Transporter Expression In Vitro
por: Esobi, Ikechukwu, et al.
Publicado: (2022) -
Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2(loxP/loxP) Villin-Cre mice
por: Kortüm, Benedikt, et al.
Publicado: (2015) -
Dermal Delivery of Constructs Encoding Cre Recombinase to Induce Skin Tumors in Pten(LoxP/LoxP);Braf(CA/+) Mice
por: Deken, Marcel A., et al.
Publicado: (2016)